648
Views
58
CrossRef citations to date
0
Altmetric
Original Article

The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process

, , , &
Pages 139-148 | Received 22 Mar 2010, Accepted 25 May 2010, Published online: 25 Jun 2010

References

  • Bhaskar K, Mohan CK, Lingam M, Reddy VP, Vobalaboina Venkateswarlu V, Rao YM. (2008). Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: In vitro and ex vivo characterization. Drug Dev Ind Pharm, 34:719–25.
  • Li S, Zhao B, Wang F, Wang M, Xie S, Wang S, . (2010). Yak interferon-alpha loaded solid lipid nanoparticles for controlled release. Res Vet Sci, 88:148–53.
  • Fang JY, Fang CL, Liu CH, Su YH. (2008). Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 70:633–40.
  • Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 266:170–84.
  • Pople PV, Singh KK. (2006). Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech, 7:91.
  • del Pozo-Rodríguez A, Delgado D, Solinís MA, Pedraz JL, Echevarría E, . (2010). Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration. Int J Pharm, 385:157–62.
  • Liu Z, Zhong Z, Peng G, Wang S, Du X, Yan D, . (2009). Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles. Drug Deliv, 16:341–7.
  • Martins S, Silva AC, Ferreira DC, Souto EB. (2009). Improving oral absorption of Salmon calcitonin by trimyristin lipid nanoparticles. J Biomed Nanotechnol, 5:76–83.
  • Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. (2008). Solid lipid nanoparticles and nanostructured lipid carriers—Innovative generations of solid lipid carriers. Curr Drug Deliv, 5:324–31.
  • Wang SL, Xie SY, Zhu LY, Wang FH, Zhou WZ. (2009). Effects of poly (lactic-co-glycolic acid) as a co-emulsifier on the preparation and hypoglycaemic activity of insulin-loaded solid lipid nanoparticles. IET Nanobiotechnol, 3:103–8.
  • Almeida AJ, Souto E. (2007). Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev, 59:478–90.
  • Glowka E, Sapin-Minet A, Leroy P, Lulek J, Maincent P. (2010). Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles. J Microencapsul, 27:25–36.
  • Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN. (2009). Design of biodegradable nanoparticles for oral delivery of doxorubicin: In vivo pharmacokinetics and toxicity studies in rats. Pharm Res, 26:492–501.
  • Kim BS, Kim CS, Lee KM. (2008). The intracellular uptake ability of chitosan-coated poly (D,L-lactide-co-glycolide) nanoparticles. Arch Pharm Res, 31:1050–4.
  • Yadav KS, Sawant KK. (2010). Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. Curr Drug Deliv, 7:51–64.
  • Gallarate M, Trotta M, Battaglia L, Chirio D. (2009). Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation. J Microencapsul, 26:394–402.
  • Sarmento B, Martins S, Ferreira D, Souto EB. (2007). Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed, 2:743–9.
  • Neumann AWG, Good KJ. (1979). Techniques of measuring contact. In: Good RJ, Stromberg RR, eds. Surface and colloid science. New York: Plenum Press, 31–92.
  • Yin YS, Chen DW, Qiao MX, Lu Z, Hu HY. (2006). Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. J Control Release, 116:337–45.
  • Florence AT. (2005). Nanoparticle uptake by the oral route: Fulfilling its potential? Drug Discov Today, 2:75–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.